Batch of adrenaline pens recalled by regulator
The Health Products Regulatory Authority (HPRA) have recalled a number of adrenaline pens out of fears that they might not work properly.
These products are used for the emergency treatment of acute allergic (anaphylactic) reactions.
According to the HRPA, the pen is failing to produce an injection, due to failure of the pen to activate and the potential for a blocked needle.
Anyone who possesses an Emerade pen for their own use or for someone in their care is being urged to ensure that their pens are brought back to their pharmacy and immediately replaced with an alternative product.
The HPRA states that no other brand of adrenaline pens is impacted by this recall.
The affected products are all batches of:
- Emerade 150mcg pre-filled pens
Emerade 300mcg pre-filled pens
Emerade 500mcg pre-filled pens
If you have not yet been contacted by your pharmacist, people are also being urged to check for any Emerade pens in your possession.
If you are in possession of any Emerade pen, return it to your pharmacy where you will receive a replacement alternative.